Ronald Lizée
Finanzdirektor/CFO bei Acrongenomics, Inc.
Profil
Ronald Lizée is currently the President & Chief Executive Officer at Gemstar Capital Properties, Inc. He is also the Chief Financial Officer at Acrongenomics, Inc. Previously, he served as the Chief Financial Officer, Treasurer & Director at PreAxia Health Care Payment Systems, Inc. from 2008 to 2011.
Additionally, he was the Chief Financial Officer at Sun World Partners, Inc. from 2008 to 2009.
Mr. Lizée obtained his undergraduate degree from the University of Saskatchewan in 1981.
Aktive Positionen von Ronald Lizée
| Unternehmen | Position | Beginn |
|---|---|---|
Acrongenomics, Inc.
 Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | 04.06.2004 |
| Gemstar Capital Properties, Inc. | Vorstandsvorsitzender | 02.03.2010 |
Ehemalige bekannte Positionen von Ronald Lizée
| Unternehmen | Position | Ende |
|---|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Finanzdirektor/CFO | 24.11.2011 |
| Sun World Partners, Inc. | Finanzdirektor/CFO | 15.01.2009 |
Ausbildung von Ronald Lizée
| University of Saskatchewan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Technology Services |
| Private Unternehmen | 3 |
|---|---|
Acrongenomics, Inc.
Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
| Sun World Partners, Inc. | Retail Trade |
| Gemstar Capital Properties, Inc. |
